158001-04-8

Basic information

• Product Name: IMidazo[1,2-a]pyridine-6-carboxylic acid, ethyl ester
• Synonyms: IMidazo[1,2-a]pyridine-6-carboxylic acid, ethyl ester
• CAS NO: 158001-04-8
• Molecular Formula: C₁₀H₁₀N₂O₂
• Molecular Weight: 190.1986
• Mol File: 158001-04-8.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• Density: 1.22±0.1 g/cm3(Predicted)
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 5.18±0.50(Predicted)
• CAS DataBase Reference: IMidazo[1,2-a]pyridine-6-carboxylic acid, ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: IMidazo[1,2-a]pyridine-6-carboxylic acid, ethyl ester(158001-04-8)
• EPA Substance Registry System: IMidazo[1,2-a]pyridine-6-carboxylic acid, ethyl ester(158001-04-8)

Safety Data

• Hazardous Substances Data: 158001-04-8(Hazardous Substances Data)

Usage

General Description

IMidazo[1,2-a]pyridine-6-carboxylic acid, ethyl ester is a type of organic compound that belongs to the class of organic compounds known as imidazo[1,2-a]pyridines. These are organic compounds containing a pyridine ring fused to an imidazole ring. The ethyl ester formation indicates the presence of an ethoxy carboxylic group attached to the molecule. This chemical is not usually discussed in terms of industrial uses or biological implications, suggesting that it could be primarily utilized in laboratory or research settings. Given its complex structure, it may be significant in organic synthesis procedures or as an intermediate for the production of other chemical compounds.

Upstream product

• 107-20-0 2-chloroethanal 
• 39658-41-8 ethyl-6-amino-nicotinate 

Downstream Products

• 139022-25-6 imidazo[1,2-a]pyridine-6-carboxylic acid 
• 372147-65-4 (Z)-ethyl α-[(triphenylphosphoranylidene)amino]-β-(imidazo[1,2-a]pyridin-6-yl)propenoate 
• 116355-16-9 6-imidazo<1,2-a>pyridinecarboxaldehyde 
• 132213-07-1 6-(hydroxymethyl)imidazo[1,2-a]pyridine 

Relevant articles and documents

P2X3 AND/OR P2X2/3 COMPOUNDS AND METHODS

The present disclosure provides novel compounds and methods for preparing and using these compounds. In one embodiment, the compounds are of the structure of formula (I), wherein R1-R7 are defined herein. In a further embodiment, these compounds are useful in method for regulating one or both of the P2X3 or P2X2/3 receptors. In another embodiment, these compounds are useful for treating pain in patients by administering one or more of the compounds to a patient. In another embodiment, these compounds are useful for treating respiratory dysfunction in patients by administering one or more of the compounds to a patient.

6-heterocyclyl pyrazolo [3,4-d]pyrimidin-4-ones and compositions and method of use thereof

Novel 6-heterocyclyl-pyrazolo[3,4-d]pyrimidin-4-ones, useful in treating cardiovascular disease, are prepared by reacting a 5-amino-1H-pyrazole-4-carboxamide with heterocyclylcarboxaldehyde or by reacting a 5-amino-1H-pyrazole-4-carbonitrile with a heterocyclylcarboxamidine, followed by diazotization and hydrolysis of the resulting 4-amino-6-heterocyclyl-pyrazolo[3,4-d]pyrimidine.